People with Parkinson's made to claim Universal Credit
On 22 July 2019, the government passed regulations that mean people with Parkinson's can now be moved on to Universal Credit from other benefits.
Could a gut infection trigger Parkinson's?
A new study published in Nature has shown that a gut infection can lead to symptoms resembling Parkinson's in mice, suggesting that the immune system may play a more central role in the condition than previously thought.
Welfare is unfair, says new report
A new report from the Disability Benefits Consortium shows how changes to the benefits system have had a devastating impact on disabled people.
New celebrity supporter Ayda Williams visits our Brain Bank
We welcomed Ayda Williams to our Brain Bank, where she met leading experts in Parkinson’s research and saw how their work is driving us closer to better treatments and a cure.
Changes to the Mental Capacity Act
An update on new legislation on mental capacity and making decisions about a person's health and care, which comes into force from April 2020.
Targeting nerve cell batteries to slow Parkinson’s progression
We’re investing nearly £1 million to find a new treatment that targets energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
New research puts serotonin at the heart of Parkinson’s
In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
HYPE protein found to target alpha-synuclein
Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
Targeting bacteria in the gut could increase effectiveness of levodopa
New research from Harvard University suggests changes to the gut could improve how a common Parkinson’s medication works.
New molecules targeting alpha-synuclein have potential for slowing Parkinson’s
Researchers in Japan have developed molecules that could be key to slowing the progression of Parkinson’s.